Development of novel therapy targeting dendritic cells for Crohn's disease
Development of novel therapy targeting dendritic cells for Crohn's disease
批准号:
15590685
负责人:
IWAO Yasushi
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
克罗恩病(CD)是一种累及胃肠道的慢性炎症过程,其特征为不连续和透壁炎症。虽然CD的病因尚未完全清楚,但越来越多的证据表明,局部免疫系统的失调在CD的发病机制中至关重要。来自人类和实验鼠结肠炎模型的研究表明,在CD中,局部免疫应答倾向于主要是T辅助细胞1型(Th 1),并通过局部释放细胞因子(如肿瘤坏死因子(TNF)-□、白细胞介素(IL)-12和IL-18)反映。然而,还没有阐明是什么触发CD中的Th 1免疫应答。本研究采用密度梯度离心、免疫磁珠法去除CD 3 ^+、CD 11b ^+和CD 16 ^+细胞,再用CD 4 ^+细胞进行阳性分离,建立了从人CD肠系膜淋巴结(MLN)中分离纯化树突状细胞的方法,并对MLN中的免疫级联反应进行了分析。从MLN获得的细胞的分析显示,DC 1的比例增加,在MLN的CD相比,溃疡性结肠炎和控制和CD的MLN的CD 4 + T淋巴细胞显示Th 1 profile.This是第一个研究报告MLN树突状细胞和MLN的CD 4 + T细胞的细胞因子谱从人类IBD患者的表征。本研究表明MLN树突状细胞在IBD的发病机制中具有重要作用。MLN可能是失调的免疫应答(如CD中的Th 1)首先发生的地方。
英文摘要
Crohn's disease(CD) is a chronic inflammatory process involving the gastrointestinal tract, characterised by discontinuous and transmural inflammation. Although the etiology of CD is not fully understood, accumulating evidence suggests that dysregulation of the local immune system is pivotal in the pathogenesis of CD. Studies from humans and experimental murine colitis models indicate that in CD, the local immune response tends to be predominantly T helper cell type 1(Th1) and is reflected by local release of cytokines such as tumor necrosis factor (TNF)-□, interleukin (IL)-12, and IL-18. However, it has not been elucidated what triggers the Th1 immune response in CD. In the present study, we attempted to establish the purification of dendrtic cells from mesenteric lymph nodes(MLN) and to analyze the immune cascade in the mesenteric lymph nodes of human CD.We established the purification of dendrtic cells from MLN by density gradient centrifugation and immunomagnetic depletion of CD3^+,CD11b^+ and CD16^+ cells followed by positive isolation with CD4^+. The analysis of cells obtained from MLNs revealed that the proportion of DC1 was increased in the MLN of CD compared to ulcerative colitis and control and that CD4+ T lymphocytes from the MLN of CD show a Th1 profile.This is the first study to report the characterization of MLN dendritic cells and cytokine profiles of the MLN CD4+ T cells from human IBD patients. This study shows that MLN dendritic cells have considerable effects in the pathogenesis of IBD. The MLN may be the place where the dysregulated immune responses, such as Th1 in CD, first occur.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Thi immune response.
克罗恩病中骨桥蛋白/Eta-1 上调可调节 Thi 免疫反应。
DOI:
--
发表时间:
2005
期刊:
GUT (in press)
影响因子:
--
作者:
[Sato T, Nakai T, Tamura N, Okamoto S, Matsuoka K, Sakuraba A, Fukushima T, Uede T, Hibi T]
通讯作者:
Hibi T
T-bet up-regulation and subsequent interleukin 12 stimulation are essential for the induction of Th1 mediated immunopathology in Croha's disease.
T-bet 上调和随后的白细胞介素 12 刺激对于克罗哈病中 Th1 介导的免疫病理学的诱导至关重要。
DOI:
--
发表时间:
2004
期刊:
Gut 53(9)
影响因子:
--
作者:
[Matsuoka K, Inoue N, Sato T, Okamoto S, Hisamatsu T, Kishi Y, Sakuraba A, Hitotsumatsu O, Fukushima T, Kanai T, Watanabe M, Ishii H, Hibi T]
通讯作者:
Hibi T
DOI:
10.1136/gut.2004.048298
发表时间:
2005-09-01
期刊:
GUT
影响因子:
24.5
作者:
[Sato, T, Nakai, T, Hibi, T]
通讯作者:
Hibi, T
Hyperexpression of inducible costimulator its contribution on lamina propria T cells in inflammatory bowel disease.
诱导共刺激物的过度表达及其对炎症性肠病固有层 T 细胞的贡献。
DOI:
--
发表时间:
2004
期刊:
Gastroenterology 126・3
影响因子:
--
作者:
[Sato T, Hibi T, et al.]
通讯作者:
et al.
DOI:
10.1053/j.gastro.2003.12.011
发表时间:
2004-03-01
期刊:
GASTROENTEROLOGY
影响因子:
29.4
作者:
[Sato, T, Kanai, T, Hibi, T]
通讯作者:
Hibi, T
共 11 条
Research of Inflammatory Bowel Disease Based on Clinical Immunology and Endoscopy
-
批准号:23590949
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:IWAO Yasushi
-
依托单位:
Establishment of cancer surveillance using serum anti-p53 antibody in patients with ulcerative colitis
-
批准号:20590748
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:IWAO Yasushi
-
依托单位:
Development of novel therapy targeting innate immunity for Crohn's disease
-
批准号:17590678
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2005
-
负责人:IWAO Yasushi
-
依托单位:
海外基金